Reference priceEUR €577.50Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Adstiladrin Suspension,for intravesical |
|---|---|
| Manufacturer | Ferring Pharmaceuticals |
| Prescription required | Yes |
Adstiladrin Suspension,for intravesical kit 20ml (nadofaragene-firadenovec vncg)
nadofaragene-firadenovec vncg
Description
Adstiladrin Suspension,for intravesical kit 20ml (nadofaragene-firadenovec vncg) is a medicine catalog record in the MediPriceHub database. Active ingredient: nadofaragene-firadenovec vncg. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Ferring Pharmaceuticals. Therapeutic category: Medicine Library > Oncology Medicines > Bladder Cancer Medicines. Pack information: 20 / 4. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
ADSTILADRIN ® is indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-Muscle Invasive Bladder Cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors.How to Use
Use nadofaragene-firadenovec vncg under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: nadofaragene-firadenovec vncg. Pack size: 20 / 4. Pack unit: box. Manufacturer: Ferring Pharmaceuticals. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Bladder Cancer Medicines. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.